The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state registermedicinal products for the medical use of the medicinal product (registration certificate No. N016117 / 01 of 05.10.2009 issued Novartis Pharma AG, Switzerland):
Proleukin (trade name of the drug)
Aldesleikin (international non-proprietary, or grouping, or chemical name medicinal product)
lyophilizate for the preparation of a solution for subcutaneous and intravenous administration, 18 million IU / ml (dosage form, dosage)
Novartis Pharmaceuticals QL Ltd, United Kingdom Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom; Novartis Pharma GmbH, Germany Roonstraj3e 25, 9Q429 Numberg, Germany (name and address of the location of the manufacturer of the medicinal product)
on the basis of a filing by an authorized legal entity LLC Novartis Pharma, Russia of a request for the cancellation of the state registration of a medicinal product.